Table 3.
Time | Not challenged | Challenged (Chal) | p-value | |||
---|---|---|---|---|---|---|
Control (n = 5) | MYCI (n = 5) | Control (n = 6) | MYCI (n = 6) | Chal | MYCI | |
0 h | 0/5 | 0/5 | 0/6 | 0/6 | N/Ab | N/A |
12 h | 0/5 | 0/5 | 0/6 | 0/6 | N/A | N/A |
1 d | 0/5 | 0/5 | 2/6 | 2/6 | 0.044 | 1.000 |
2 d | 0/5 | 0/5 | 6/6 | 6/6 | <0.001 | 1.000 |
3d | 0/5 | 0/5 | 6/6 | 5/6 | <0.001 | 0.670 |
4 d | 0/5 | 0/5 | 4/6 | 2/6 | 0.009 | 0.338 |
5 d | 0/5 | 0/5 | 4/6 | 3/6 | 0.003 | 0.647 |
6 d | 0/5 | 0/5 | 3/5c | 3/6 | 0.006 | 0.890 |
7 d | 0/5 | 0/5 | 2/5 | 2/6 | 0.034 | 0.916 |
Total | 0/45 | 0/45 | 27/52 | 23/54 | <0.001 | 0.460 |
aNewborn piglets received an oral challenge with 3 × 103.5 TCID50 of PEDV in PBS or PBS only and daily administration 60 mg of the MYCI mixture suspended in milk replacer or the vehicle for 7 days. Presence of the PEDV in feces was determined by reverse transcription-polymerase chain reaction. Data represent the number of PEDV-positive animals per total animals
bN/A, Not applicable
cOne animal died